JPMorgan Chase & Co. increased its position in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) by 129.3% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 4,851 shares of the company’s stock after purchasing an additional 2,735 shares during the period. JPMorgan Chase & Co.’s holdings in Direxion Daily S&P Biotech Bull 3x Shares were worth $625,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Foundations Investment Advisors LLC boosted its stake in Direxion Daily S&P Biotech Bull 3x Shares by 13.0% in the 3rd quarter. Foundations Investment Advisors LLC now owns 4,617 shares of the company’s stock worth $594,000 after purchasing an additional 530 shares during the period. SG Americas Securities LLC boosted its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares by 49.3% during the 3rd quarter. SG Americas Securities LLC now owns 3,199 shares of the company’s stock valued at $412,000 after buying an additional 1,057 shares during the period. Tidal Investments LLC acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter valued at $9,012,000. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter valued at $43,000. Finally, Traynor Capital Management Inc. boosted its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares by 6.7% during the 3rd quarter. Traynor Capital Management Inc. now owns 10,763 shares of the company’s stock valued at $1,386,000 after buying an additional 674 shares during the period.
Direxion Daily S&P Biotech Bull 3x Shares Price Performance
Shares of NYSEARCA:LABU opened at $95.70 on Tuesday. The firm has a fifty day moving average of $101.69 and a two-hundred day moving average of $120.24. Direxion Daily S&P Biotech Bull 3x Shares has a 12-month low of $78.46 and a 12-month high of $176.99.
Direxion Daily S&P Biotech Bull 3x Shares Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Further Reading
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- How Can Investors Benefit From After-Hours Trading
- Sizing Up a New Opportunity for NVIDIA Investors
- How to Buy Cheap Stocks Step by Step
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- What is a Special Dividend?
- The 3 Biggest M&A Stock Opportunities for 2025
Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report).
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.